Faculty of Medicine Alexandria University
Alexandria, Egypt
NCT Number: NCT07360769
The goal of this clinical trial is to detect if lower dialysate flow rate can affect hemodialysis adequacy , dialysis recovery time and patients quality of life.
The main questions it aims to answer are:
does low dialysate flow affect hemodialysis adequacy? does green dialysis achievable without affecting hemodialysis adequacy? Researchers will compare hemodialysis session of high dialysate flow to that with low dialysate flow.
Participants will:
underwent hemodialysis for a week with low dialysate flow and another week with high dialysate flow.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Alexandria, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The aim of this study is to check whether change of dialysate flow from 500ml/min to 300ml/min has a significant impact on dialysis adequacy , dialysis recovery time and patient reported outcome measures in maintenance hemodialysis patients.
Time frame: Two weeks
Time frame: Two weeks
Time frame: two weeks
Time frame: Tow weeks
Alexandria University
Other
Low Dialysate Flow: Its Effect on Hemodialysis Adequacy, Dialysis Recovery Time and Patient Reported Outcome Measures.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07253831
Anxiety, Anxiety Disorders
Al Qādisīyah, Aldiwanyah, Iraq
View Trial DetailsNCT07436338
Chronic Disease, Disease Attributes
Seoul, Jongno-gu, South Korea
View Trial DetailsNCT07303088
Chronic Disease, Disease Attributes
Sfax, Sfax Ville, Tunisia
View Trial DetailsNCT05345717
Chronic Disease, Disease Attributes
Chicago, Illinois, United States
View Trial Details